P&G, Pfizer Disagree On Antiplaque Claims Support, Stannous Fluoride
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble and Pfizer take opposing views on the way therapeutic stand-alone antiplaque claims should be regulated in comments submitted to FDA Feb. 20